The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealing

24 Apr 2018 17:04

RNS Number : 9918L
Omega Diagnostics Group PLC
24 April 2018
 

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

PDMR Dealing

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 24 April 2018 that Edward Valente, Group R&D Director of the Company has purchased 124,044 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a price of 14.5 pence per Ordinary Share.

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Edward Valente

2.

Reason for notification

b)

Position / status

Group R&D Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Purchase of Ordinary Shares

 GB00B1VCP282

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Volume(s)

Price(s) £

124,044

0.145

 

d)

Aggregated information

Aggregated volume Price

Aggregate Volume(s)

Volume weighted average Price) £

124,044

0.145

 

e)

Date of the transaction

24/04/18

f)

Place of the transaction

LSE

 

Contacts:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Colin King, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

Jag Grewal, Group Sales and Marketing Director

 

 

 

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)

 

Camille Gochez (Corporate Broking)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKQDKABKDBQB
Date   Source Headline
12th Nov 202010:04 amRNSResponse to media comment
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
11th Nov 20207:00 amRNSInvestor Presentation - Q&A update
10th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:01 amRNSPrice Monitoring Extension
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 202010:45 amRNSExercise of Options and Total Voting Rights
6th Nov 20209:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20207:00 amRNSChinese approval for Food Detective® test
30th Oct 20203:00 pmRNSExercise of Options and Total Voting Rights
29th Oct 20206:07 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSTrading update and notice of interim results
20th Oct 202011:00 amRNSExercise of Options and Total Voting Rights
20th Oct 20207:00 amRNSNotice of Trading Update and Investor Presentation
19th Oct 20207:00 amRNSUK-RTC contract for the Supply of Goods
14th Oct 20207:45 amRNSExercise of Options and Total Voting Rights
9th Oct 20204:15 pmRNSExercise of Options and Total Voting Rights
7th Oct 20207:00 amRNSUK Government contract for UK-RTC
6th Oct 20205:45 pmRNSHolding(s) in Company
6th Oct 20204:46 pmRNSUK Government contract for UK-RTC
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
2nd Oct 202012:00 pmRNSPreliminary report published by Ulster University
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSInvestor Presentation
24th Sep 20202:05 pmRNSSecond Price Monitoring Extn
24th Sep 20202:00 pmRNSPrice Monitoring Extension
15th Sep 20205:51 pmRNSExercise of Options and Total Voting Rights
15th Sep 20209:45 amRNSHolding(s) in Company
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20202:05 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
10th Sep 202010:11 amRNSHolding(s) in Company
7th Sep 20202:33 pmRNSStmnt re Share Price Movement
7th Sep 20207:00 amRNSCompletion of AbC-19 self-test usability study
3rd Sep 20207:00 amRNSCE-Mark for Mologic COVID-19 antibody test
1st Sep 20204:07 pmRNSExercise of Options and Total Voting Rights
28th Aug 20209:45 amRNSHolding(s) in Company
26th Aug 202011:20 amRNSResult of AGM
26th Aug 20207:00 amRNSExercise of Options and Total Voting Rights
24th Aug 20209:30 amRNSExercise of Options and Total Voting Rights
21st Aug 20207:00 amRNSWHO Prequalification received

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.